NPVS: rapidly hydrolyzed in the body, the formation of valdekoxyb selectively inhibits COH-2, thereby reducing the formation of prostaglandins.Reduces the manifestations of inflammatory reactions and the sensitivity of pain receptors.The physiological processes of tissues that rely on this enzyme, including the stomach and intestinal mucosa, have little effect on DRH-1 and do not affect platelet function.